Clinical Trials

200 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT04690972 2026-02-12

LivMOD

800 enrolled

Hepatitis D, Fibrosis, Hepatitis B, Hepatitis C, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT07398716 2026-02-11

Intraoperative Assessment of Distal Resection Margins Using Frozen Section in Mid and Low Rectal Cancer Surgery

Phase NA Completed

99 enrolled

Rectal Neoplasms

NCT07403916 2026-02-11

Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer

Active not recruiting

90 enrolled

Stomach Neoplasms

NCT05177484 2026-01-30

PICoC

Phase 3 Completed

40 enrolled 19 charts

Colonic Neoplasms

NCT07297433 2026-01-23

Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery

60 enrolled

Colorectal Neoplasms

NCT04763642 2026-01-21

The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone

Phase NA Completed

320 enrolled

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT06983639 2026-01-15

FIT

4,000 enrolled

Polyps, Colorectal Neoplasms

NCT07342231 2026-01-15

FAP-1

60 enrolled

Pancreatic Neoplasms

NCT05345613 2026-01-13

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Phase 4 Recruiting

200 enrolled

Phase 3 Not yet recruiting

Colonic Neoplasms

NCT07332221 2026-01-12

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

435 enrolled

Phase 2 Not yet recruiting

Esophageal Neoplasms

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

38 enrolled

Pancreatic Cancer Liver Metastases

NCT07334431 2026-01-12

Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer

Phase 1/2 Recruiting

45 enrolled

Stomach Neoplasms

NCT06282016 2026-01-07

Risk Factors for Neuroendocrine Neoplasms

14,250 enrolled

Colorectal Neoplasms

NCT07310836 2025-12-30

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

Not yet recruiting

300 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular

NCT07306481 2025-12-29

The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer

40 enrolled

Carcinoma, Hepatocellular

NCT01618643 2025-12-24

Aceto-whitening in the Assessment of Gastrointestinal Neoplasia

197 enrolled

Barrett Esophagus

NCT04937647 2025-12-23

NEW-AGE

1,650 enrolled

Gastrointestinal Neoplasms

NCT07291141 2025-12-19

DETECT-HCC

600 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Sarcopenia

NCT07293468 2025-12-19

BIIRTH

Phase 2/3 Recruiting

106 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular

NCT07295002 2025-12-19

Co-SNARE

10 enrolled

Stomach Neoplasms

NCT07272538 2025-12-18

FRAIL-GI

84 enrolled

Frailty, Gastrointestinal Neoplasms

NCT07284992 2025-12-16

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

Phase 2 Recruiting

208 enrolled

Rectal Neoplasms

NCT03015038 2025-12-10

IMCO

100 enrolled

Colonic Neoplasms

NCT03071458 2025-12-10

MUTHEC

808 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

Phase 2/3 Recruiting

100 enrolled

Colonic Neoplasms

NCT01555450 2025-12-04

PRADO

Phase NA Completed

28,929 enrolled

Colorectal Cancer Screening

NCT06313801 2025-11-21

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

Phase 2 Recruiting

106 enrolled

Stomach Neoplasms

NCT06940947 2025-11-20

ETHOS

Phase 3 Recruiting

434 enrolled

Colonic Neoplasms

NCT01693835 2025-11-18

"Cancersensor": Circadian Rhythms

32 enrolled

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07234682 2025-11-18

Impact of Anxiety-Sleep Symptom Cluster on Immune Function and Quality of Life in Colorectal Cancer

103 enrolled

Anxiety Disorders, Colorectal Neoplasms

NCT07208786 2025-10-06

Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery: a Randomized Controlled Study

110 enrolled

Colorectal Neoplasms, Anastomotic Leak

NCT04780256 2025-10-03

Endoscopic Resection of Gastrointestinal Neoplasms

2,000 enrolled

Colonic Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT04776655 2025-10-02

LIBImAb

Phase 3 Recruiting

280 enrolled

Phase 2 Active not recruiting

Colorectal Neoplasms

NCT05177068 2025-10-02

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

42 enrolled

Stomach Neoplasms

NCT07203690 2025-10-02

Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology

Not yet recruiting

7,000 enrolled

Esophageal Neoplasms

NCT05971108 2025-09-24

REVISE-HCC

600 enrolled

Phase EARLY_PHASE1 Recruiting

Fibrosis, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT07106814 2025-09-15

Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

36 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Liver Neoplasms

NCT07170345 2025-09-12

HCC-MVI-CAD

400 enrolled